$MGEN It’s anybody’s guess. -FDA Orphan drug approval for Cobomarsen -incoming partnerships? -Conference call on August 5th There’s lots to speculate about here. Enough catalysts to bring some gamblers in to the table. If the bio market is bullish for the next week, maybe we can see a repeat or surpass the 1.60 open on Friday.